Item 5.07 Submission of Matters to a Vote of Security Holders (a) The Pfizer Inc. (the "Company") Annual Meeting of Shareholders was held on April 22, 2021. (b) Shareholders voted on the matters set forth below.



1.  The nominees for election to the Company's Board of Directors set forth in Item 1 to the Company's Proxy Statement filed with the U.S. Securities and
Exchange Commission on March 12, 2021 were elected to hold office until the Company's next Annual Meeting of Shareholders, based upon the following
votes:
Nominee                                              Votes For             Votes Against                 Abstentions            Broker non-vote
Ronald E. Blaylock                               3,552,128,581                75,310,205                  17,769,916                872,247,240
Albert Bourla                                    3,403,798,711               212,217,144                  29,192,847                872,247,240
Susan Desmond-Hellmann                           3,602,587,186                27,007,655                  15,613,861                872,247,240
Joseph J. Echevarria                             3,067,343,922               551,543,052                  26,321,728                872,247,240
Scott Gottlieb                                   3,604,408,886                24,247,147                  16,552,669                872,247,240
Helen H. Hobbs                                   3,591,164,311                38,498,000                  15,546,391                872,247,240
Susan Hockfield                                  3,606,052,119                24,001,809                  15,154,774                872,247,240
Dan R. Littman                                   3,598,774,848                28,603,952                  17,829,902                872,247,240
Shantanu Narayen                                 3,590,073,401                38,138,233                  16,997,068                872,247,240
Suzanne Nora Johnson                             3,477,324,059               151,820,880                  16,063,763                872,247,240
James Quincey                                    3,588,511,169                40,095,580                  16,601,953                872,247,240
James C. Smith                                   3,575,587,764                53,048,897                  16,572,041                872,247,240



2.  The proposal to ratify the selection of KPMG LLP as the Company's independent registered public
accounting firm for the 2021 fiscal year was approved based upon the following votes:

Votes for approval                           4,291,626,166
Votes against                                  208,758,238
Abstentions                                     17,071,538
Broker non-votes                                       n/a

3. The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes:



Votes for approval                           3,355,194,651
Votes against                                  258,664,414
Abstentions                                     31,349,637
Broker non-votes                               872,247,240

4. The shareholder proposal regarding independent chair policy was not approved based upon the following votes:



Votes for approval                                   1,347,236,928
Votes against                                        2,260,655,067
Abstentions                                             37,316,707
Broker non-votes                                       872,247,240

--------------------------------------------------------------------------------



5. The shareholder proposal regarding political spending report was not approved based upon the following
votes:

Votes for approval                              1,636,845,263
Votes against                                   1,829,127,739
Abstentions                                       179,235,700
Broker non-votes                                  872,247,240

6. The shareholder proposal regarding report on access to COVID-19 products was not approved based upon the
following votes:

Votes for approval                              1,011,019,874
Votes against                                   2,562,817,160
Abstentions                                        71,371,668
Broker non-votes                                  872,247,240

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses